13-11-2024 |
PM |
|
FULC |
Fulcrum Therapeutics, Inc. |
227.14 |
N/A |
-0.40 |
-0.39 |
Fulcrum Therapeutics GAAP EPS of -$0.35 beats by $0.05 [11/13/2024 7:21 AM] |
3.57 |
-0.07 (-1.95%) |
3.86 |
0.22 (6.04%) |
2.87 - 13.70 |
719,245 |
790,000 |
31,107 |
|
|
31-07-2024 |
PM |
|
FULC |
Fulcrum Therapeutics, Inc. |
523.96 |
0.87 |
-0.06 |
-0.38 |
Fulcrum Therapeutics GAAP EPS of $0.87 beats by $0.88, revenue of $80M beats by $38.89M [7/31/2024 7:18 AM] |
9.25 |
0.84 (9.99%) |
8.96 |
0.55 (6.54%) |
3.14 - 13.70 |
1,273,702 |
460,000 |
12,913 |
|
|
13-05-2024 |
PM |
|
FULC |
Fulcrum Therapeutics, Inc. |
464.51 |
-0.43 |
-0.44 |
-0.41 |
Fulcrum Therapeutics GAAP EPS of -$0.43 in-line [5/13/2024 7:22 AM] |
7.40 |
-0.07 (-0.94%) |
8.35 |
0.88 (11.78%) |
2.65 - 13.70 |
1,710,608 |
290,000 |
180,247 |
|
|
27-02-2024 |
PM |
|
FULC |
Fulcrum Therapeutics, Inc. |
593.50 |
-0.40 |
-0.44 |
-0.50 |
Fulcrum Therapeutics GAAP EPS of -$0.40 beats by $0.04, revenue of $0.87M beats by $0.48M [2/27/2024 7:10 AM] |
10.25 |
0.52 (5.34%) |
9.90 |
0.17 (1.75%) |
2.25 - 10.50 |
1,384,993 |
580,000 |
1,220 |
|
|
07-11-2023 |
PM |
|
FULC |
Fulcrum Therapeutics, Inc. |
240.49 |
-0.39 |
-0.44 |
-0.50 |
Fulcrum Therapeutics GAAP EPS of -$0.39 beats by $0.04, revenue of $0.76M misses by $0.29M [11/7/2023 7:16 AM] |
4.30 |
0.71 (19.78%) |
3.66 |
0.07 (1.99%) |
2.25 - 15.00 |
1,150,012 |
410,000 |
1,317 |
|
|
03-08-2023 |
PM |
|
FULC |
Fulcrum Therapeutics, Inc. |
229.13 |
-0.38 |
-0.44 |
-0.83 |
Fulcrum Therapeutics GAAP EPS of -$0.38 beats by $0.06, revenue of $0.9M misses by $0.06M [8/3/2023 10:18 AM] |
3.85 |
0.03 (0.79%) |
4.10 |
0.28 (7.33%) |
2.25 - 15.00 |
709,290 |
560,000 |
128 |
|
|
15-05-2023 |
PM |
7:15 AM ET (May 15) |
FULC |
Fulcrum Therapeutics, Inc. |
196.39 |
-0.41 |
-0.47 |
-0.64 |
Fulcrum Therapeutics GAAP EPS of -$0.41 beats by $0.05, revenue of $0.3M misses by $0.68M [5/15/2023 7:12 AM] |
3.63 |
0.36 (10.93%) |
3.42 |
0.15 (4.59%) |
2.25 - 15.00 |
829,670 |
770,000 |
3,086 |
|
|
09-03-2023 |
PM |
7:15 AM ET (Mar 9) |
FULC |
Fulcrum Therapeutics, Inc. |
792.42 |
-0.50 |
-0.49 |
-0.58 |
Fulcrum Therapeutics GAAP EPS of -$0.50 misses by $0.01, revenue of $0.7M misses by $1.19M [3/9/2023 7:12 AM] |
4.82 |
-1.44 (-23.00%) |
5.23 |
-1.03 (-16.45%) |
3.21 - 24.79 |
3,133,035 |
2,120,000 |
38,160 |
|
|
08-11-2022 |
PM |
7:00 AM ET (Nov 8) |
FULC |
Fulcrum Therapeutics, Inc. |
317.44 |
-0.50 |
-0.62 |
-0.57 |
Fulcrum Therapeutics GAAP EPS of -$0.51 beats by $0.11, revenue of $1.18M misses by $1.36M [11/8/2022 7:20 AM] |
6.50 |
0.89 (15.86%) |
0.0 |
0.0 (0.00%) |
3.21 - 24.79 |
463,919 |
340,000 |
0 |
|
|
11-08-2022 |
PM |
7:00 AM ET (Aug 11) |
FULC |
Fulcrum Therapeutics, Inc. |
229.16 |
-0.83 |
-0.66 |
-0.60 |
Fulcrum Therapeutics GAAP EPS of -$0.83 misses by $0.17, revenue of $1.9M misses by $1.06M [8/11/2022 7:23 AM] |
7.54 |
-0.22 (-2.84%) |
7.38 |
-0.38 (-4.90%) |
3.21 - 33.10 |
514,052 |
540,000 |
571 |
|
|
09-05-2022 |
PM |
7:00 AM ET (May 9) |
FULC |
Fulcrum Therapeutics, Inc. |
359.61 |
-0.64 |
-0.63 |
-0.54 |
Fulcrum Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $2.6M misses by $1.34M [5/9/2022 7:05 AM] |
7.64 |
-0.99 (-11.47%) |
8.22 |
-0.41 (-4.75%) |
6.85 - 33.10 |
1,123,082 |
720,000 |
200 |
|
|
03-03-2022 |
PM |
7:00 AM ET (Mar 3) |
FULC |
Fulcrum Therapeutics, Inc. |
446.04 |
-0.58 |
-0.65 |
-0.64 |
Fulcrum Therapeutics GAAP EPS of -$0.58 beats by $0.09, revenue of $5.06M beats by $1.54M [3/3/2022 7:14 AM] |
11.07 |
-0.03 (-0.27%) |
11.06 |
-0.04 (-0.36%) |
6.85 - 33.10 |
385,380 |
290,000 |
1,602,264 |
|
|
04-11-2021 |
PM |
7:00 AM ET (Nov 4) |
FULC |
Fulcrum Therapeutics, Inc. |
886.97 |
-0.57 |
-0.64 |
-0.70 |
Fulcrum Therapeutics beats on revenue [11/4/2021 7:05 AM] |
21.15 |
0.67 (3.27%) |
21.15 |
0.0 (0.00%) |
6.85 - 33.10 |
1,021,981 |
370,000 |
4,760 |
|
|
10-08-2021 |
PM |
7:00 AM ET (Aug 10) |
FULC |
Fulcrum Therapeutics, Inc. |
264.70 |
-0.60 |
-0.65 |
-0.66 |
Fulcrum Therapeutics beats on revenue [8/10/2021 7:08 AM] |
18.77 |
10.44 (125.33%) |
13.19 |
4.86 (58.34%) |
6.85 - 22.09 |
98,865,897 |
230,000 |
4,238,718 |
|
|
06-05-2021 |
PM |
7:00 AM ET (May 6) |
FULC |
Fulcrum Therapeutics, Inc. |
371.48 |
-0.54 |
-0.66 |
-0.81 |
Fulcrum Therapeutics beats on revenue [5/6/2021 7:12 AM] |
10.58 |
0.51 (5.06%) |
10.20 |
0.13 (1.29%) |
7.01 - 22.39 |
83,881 |
90,000 |
2,251 |
|
|
04-03-2021 |
PM |
7:00 AM ET (Mar 4) |
FULC |
Fulcrum Therapeutics, Inc. |
402.91 |
-0.64 |
-0.72 |
-0.71 |
Fulcrum Therapeutics EPS beats by $0.08, beats on revenue [3/4/2021 7:11 AM] |
12.52 |
-2.07 (-14.19%) |
14.59 |
0.0 (0.00%) |
7.01 - 22.39 |
197,677 |
88,395 |
519 |
|
|
10-11-2020 |
PM |
7:00 AM ET (Nov 10) |
FULC |
Fulcrum Therapeutics, Inc. |
320.65 |
-0.70 |
-0.66 |
-0.97 |
Fulcrum Therapeutics EPS misses by $0.03, beats on revenue [11/10/2020 7:08 AM] |
10.88 |
0.06 (0.55%) |
10.82 |
0.0 (0.00%) |
6.66 - 22.96 |
135,220 |
213,932 |
504 |
|
|
11-08-2020 |
PM |
7:00 AM ET (Aug 11) |
FULC |
Fulcrum Therapeutics, Inc. |
469.41 |
-0.66 |
-0.80 |
-9.21 |
Fulcrum Therapeutics EPS beats by $0.13 [8/11/2020 7:03 AM] |
9.39 |
-7.73 (-45.15%) |
11.70 |
-5.42 (-31.66%) |
4.37 - 22.96 |
1,127,330 |
31,509 |
14,472 |
|
|
13-05-2020 |
PM |
7:00 AM ET (May 13) |
FULC |
Fulcrum Therapeutics, Inc. |
410.02 |
-0.81 |
-0.75 |
0.00 |
Fulcrum Therapeutics EPS misses by $0.06 [5/13/2020 7:04 AM] |
16.48 |
1.57 (10.53%) |
0.0 |
0.0 (0.00%) |
4.37 - 22.96 |
349,158 |
76,281 |
0 |
|
|